I listened to the VRUS presentation at the Goldman Sachs Healthcare Conference on 6/9/09 and they give a very brief mention of the safety issues seen in the Phase 1a trial of PSI-7851. I can't make out what the presenter is saying but it's just past the 7 minute mark if anyone wants to try and decipher. It sounds like "ecd pads" or something but I have no idea.
The speaker said, “ECG path,” i.e. electrocardiograph pathology.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”